easier with increasing blood flow in the tail. During measurements, unanesthetized rats were placed on a small hammock.
In men, the systolic and the diastolic blood pressure of the radial artery were measured by the auscultation method. I. Effect of oral GABA on normotensive rats; Twenty Wistar rats of about 58 days old were fed for 12 weeks under the condition described in methods and to ten of them, GABA (1 gm/day) was orally given for 8 weeks from the 5th week. At the conclusion of experiments, they were killed and their brain, lung, heart, spleen, liver and kidney were stained with Haematoxylineosin and examined histologically. However, no appreciable histological changes between control rats and GABA-fed rats were observed. II. Effect of oral GABA on hypertensive rats; The blood pressure levels of experimental renal hypertensive rats tended to fluctuate considerably on the initial phase, but sooner or later became relatively stationary. More than ten mg of GABA (0.01-1 gm) per day was applied orally at such stages to hypertensive rats weighing about 200-300 gm. The depressant effect of GABA varied considerably between individuals, but it was obviously recognized in nearly all the hypertensive rats (93% ), when more than 30 mg was given every day (TABLE 1) .
After application of 50 mg of GABA, fall of blood pressure amounted to 28 mm Hg on the average in 7 hypertensive rats (P<0.001).
In TABLE 2, the dose-effect relation of GABA in the same rats is shown.
The depressant effect of orally administered GABA appeared within one or two days in some hypertensive rats, but in others it was observed at first after a few days (FIG. 1) . Thereafter, its effect was usually maintained during the administration and disappeared within one week after interruption of the applica- On the other hand, no appreciable change was observed in the blood pressure Effect of subcutaneous GABA on blood pressure of rats; When 5 mg of GABA in 0.1 ml were injected subcutaneously in three normotensive rats, no effect on blood pressure was observed. However, when the same amount of GABA was injected in three hypertensive rats, in two rats remarkable decreases and in another rat a slight decrease were observed. Its effect reached to peak within one or five minutes after injection and continued for more than thirty minutes. Subsequently, the effects of GABA and reserpine were compared in the three same hypertensive rats. 0.2 mg of reserpine was subcutaneously injected. The maximal fall in blood pressure was of the same order in both cases, but the effect of reserpine appeared after a longer latency and lasted for a longer period (FIG. 3) .
Experiment II
I. Effect of GABA on healthy men, In eleven healthy adult men, 1-3 mg per kg of GABA was injected subcutaneously and its effects on respiration, blood pressure, electrocardiogram and electroencephalogram were observed. In nine cases, no appreciable changes took place in respiration, but in two cases remarkable acceleration occurred: in one subject respiration rate was increased from 24/min to 66/min and in another from 16/min to 33/min. The heart rate increased by 21-55/min in seven cases, but decreased by 27/min in one case. Blood pressure tended to elevate in all the cases, exclusive of one. But, the elevation of blood pressure was within 10 mm Hg, except for two cases, where increases in systolic blood pressure amounted respectively to 32 and 54 mm Hg. On the other hand, EEG and EKG were not affected by the injection of GABA.
Besides these effects, all the subjects reported some sensation of flushing similar to that induced by intravenous injection of CaCl2 , a slight numbness in the limbs, a pricking sensation in the skin, respiratory discomfort and headache. Moreover, they noticed dry mouth and subsequently increase in saliva secretion. All the objective and subjective effects of GABA were usually transient and disappeared within twenty minutes. These effects were likewise observed after the skin to be injected was previously anesthetized by novocaine.
As above described, the effect of subcutaneous GABA was not so severe , though more or less uncomfortable. However, there was one exceptional case, where striking decrease in blood pressure (by 54 mm Hg) lasted for more than one hour.
Subsequently, GABA (3 gm/day) was orally administered to four healthy persons for one month and its effect on blood pressure was observed. Oral GABA did not show any depressant effect or other appreciable side effects in all the cases.
II. Effects of GABA on hypertensive patients; GABA (3 gm/day) was applied to 25 hospitalized patients suffering from essential hypertension.
GABA produced a more or less remarkable depressant effect in 22 persons (88 % ) . The lowering of blood pressure level by oral GABA amounted to 45 .8 mm Hg in systolic and to 23.2 mm Hg in diastolic pressure on the average.
The systolic and diastolic blood pressure of the treated patients were gradually lowered within 1-3 days or a few more and reached a minimal level which was usually not below the normal blood pressure level within one or two weeks after application.
The lowered level was usually maintained during the application , but returned to the previous elevated level within a few days , if the treatment was interrupted.
The depressant effect of GABA was more prominent in patients of higher elevated blood pressure level and was accompanied with disappearance of selfnoticed symptoms such as headache, numbness in the arm, singing in the ear.
To six normotensive patients who were admitted to the same hospital, GABA (3 gm/day) was given for about five weeks, but no appreciable change in blood pressure and no side effects were observed. 3. On the contrary, GABA reduced the elevated blood pressure of experimental renal hypertensive rats at the doses of more than thirty mg per day. Its effect was maintained during the application, and disappeared within one week after the interruption of treatment. 4. When glutamate or aspartic acid of 50 mg per day was orally applied for three weeks, no change was observed in blood pressure of hypertensive rats. 5. GABA, administered subcutaneously was also more effective in hypertensive rats than in normotensive ones. 6. Subcutaneous injections of GABA (1-3 mg per kg) on normotensive subjects produced slight uncomfortable side effects. 7. GABA, if administered orally three g per day, did not cause any appreciable effects on normotensive persons, but it lowered remarkably the elevated blood pressure of patients.
